Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients
Bariatric Surgery Candidate, Post-operative Pain
About this trial
This is an interventional treatment trial for Bariatric Surgery Candidate focused on measuring liposomal bupivacaine, Exparel
Eligibility Criteria
Inclusion Criteria: patients who are undergoing a laparoscopic sleeve gastrectomy for severe obesity who are between 13 and 2018 years of age. Only patients treated at the Children's Hospital of Richmond at VCU will be included. Exclusion Criteria: patients less than 13 or greater than 2018 years of age patients with an allergy to bupivacaine any patients undergoing any additional procedures at the time of the laparoscopic sleeve gastrectomy. English or Spanish proficiency will be necessary.
Sites / Locations
- Virginia Commonwealth UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Experiemental
Standard of Care
Subjects will be treated with liposomal bupivacaine (study drug) after undergoing bariatric surgery.
Subjects will be treated with standard bupivacaine after undergoing bariatric surgery.